Page results
-
The Integrated Children’s and Adolescent Service has been established to provide complementary care alongside orthodox treatments. The clinic sees children up to 18 years old with a wide variety of illnesses.
-
Information about the integrated general medicine service at the Royal London Hospital for Integrated Medicine.
-
Information about the integrated occupational therapy service at the Royal London Hospital for Integrated Medicine
-
This page aims to provide information about the syndrome haemophagocytic lymphohistiocytosis (HLH).
-
The Ataxia Centre brings together a team of specialists, with expertise in the diagnosis, management and research of all forms of ataxia.
-
We offer comprehensive assessment, diagnostic services and investigation for all forms of the disease including neuropsychology, neurophysiology, imaging, genetic testing, and tissue diagnosis.
-
A guide created by The Red Cell Network with expert patient insight from Elaine Tappin, Miriam Santos Freire and Nneka Smith.
-
The department specialises in the assessment and management of Complex Neuropsychiatric conditions occurring in the context of neurological disease.
-
A drop-in service providing support, practical advice and information.
-
Skeletal muscle channelopathies are rare neuromuscular diseases that cause symptoms of episodic muscle weakness/paralysis or cause difficulty in relaxing muscles (the muscle can feel stuck or cramped) once they are contracted.
File results
-
FOI/2023/0356 - Current wait time for referral to treatment with a consultant for osteoporosis
-
FOI/2023/0353 - Junior doctors remuneration for days on strike/will be on strike
-
FOI/2023/0352 - Data security training, data breach reporting, security budgets
-
FOI/2023/0345 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI/2023/0344 - Number of neonatal and stillbirth deaths since January 2013
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0326 - Risk management system reporting rates for adverse events
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0327 - NHS long-term plan/ prevention strategy